- Home
- PPSI vs PYPD Comparison
PPSI vs PYPD Comparison
Compare PPSI & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- PYPD
- Stock Information
- Founded
- PPSI 2008
- PYPD 2008
- Country
- PPSI United States
- PYPD Israel
- Employees
- PPSI N/A
- PYPD N/A
- Industry
- PPSI Electrical Products
- PYPD Medical/Dental Instruments
- Sector
- PPSI Industrials
- PYPD Health Care
- Exchange
- PPSI Nasdaq
- PYPD Nasdaq
- Market Cap
- PPSI 30.0M
- PYPD 26.7M
- IPO Year
- PPSI N/A
- PYPD 2020
- Fundamental
- Price
- PPSI $2.48
- PYPD $2.77
- Analyst Decision
- PPSI Strong Buy
- PYPD Strong Buy
- Analyst Count
- PPSI 1
- PYPD 2
- Target Price
- PPSI $12.00
- PYPD $10.50
- AVG Volume (30 Days)
- PPSI 64.3K
- PYPD 15.1K
- Earning Date
- PPSI 04-15-2025
- PYPD 05-14-2025
- Dividend Yield
- PPSI 59.76%
- PYPD N/A
- EPS Growth
- PPSI N/A
- PYPD N/A
- EPS
- PPSI 2.96
- PYPD N/A
- Revenue
- PPSI $22,879,000.00
- PYPD N/A
- Revenue This Year
- PPSI $23.90
- PYPD N/A
- Revenue Next Year
- PPSI $19.35
- PYPD N/A
- P/E Ratio
- PPSI $0.85
- PYPD N/A
- Revenue Growth
- PPSI 105.82
- PYPD N/A
- 52 Week Low
- PPSI $2.25
- PYPD $2.30
- 52 Week High
- PPSI $7.00
- PYPD $4.75
- Technical
- Relative Strength Index (RSI)
- PPSI 37.88
- PYPD 52.30
- Support Level
- PPSI $2.31
- PYPD $2.71
- Resistance Level
- PPSI $2.75
- PYPD $2.89
- Average True Range (ATR)
- PPSI 0.15
- PYPD 0.15
- MACD
- PPSI -0.01
- PYPD 0.02
- Stochastic Oscillator
- PPSI 29.93
- PYPD 40.00
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.